Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Taletrectinib is a next-generation, brain-penetrant, selective tyrosine kinase inhibitor (TKI) that targets ROS1 and NTRK fusion-positive cancers. It is designed to improve efficacy, overcome resistance to first-generation ROS1 inhibitors, and address brain metastasis while minimizing neurological side effects
see also:
Taletrectinib & Non-Small-Cell Lung Carcinoma (NSCLC) (ROS1 +)
…